QIAGEN EPS - Earnings per Share 2006-2021 | QGEN

QIAGEN annual and quarterly earnings per share history from 2006 to 2021. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • QIAGEN EPS for the quarter ending September 30, 2021 was $0.57, a 714.29% increase year-over-year.
  • QIAGEN EPS for the twelve months ending September 30, 2021 was $2.56, a 208.43% increase year-over-year.
  • QIAGEN 2020 annual EPS was $1.53, a 950% decline from 2019.
  • QIAGEN 2019 annual EPS was $-0.18, a 121.95% decline from 2018.
  • QIAGEN 2018 annual EPS was $0.82, a 382.35% increase from 2017.
QIAGEN Annual EPS
2020 $1.53
2019 $-0.18
2018 $0.82
2017 $0.17
2016 $0.34
2015 $0.55
2014 $0.48
2013 $0.30
2012 $0.56
2011 $0.42
2010 $0.62
2009 $0.67
2008 $0.46
2007 $0.29
2006 $0.48
2005 $0.43
QIAGEN Quarterly EPS
2021-09-30 $0.57
2021-06-30 $0.52
2021-03-31 $0.56
2020-12-31 $0.91
2020-09-30 $0.07
2020-06-30 $0.38
2020-03-31 $0.17
2019-12-31 $0.21
2019-09-30 $-0.71
2019-06-30 $0.19
2019-03-31 $0.13
2018-12-31 $0.26
2018-09-30 $0.26
2018-06-30 $0.16
2018-03-31 $0.14
2017-12-31 $-0.18
2017-09-30 $0.21
2017-06-30 $0.06
2017-03-31 $0.08
2016-12-31 $0.03
2016-09-30 $0.15
2016-06-30 $0.09
2016-03-31 $0.07
2015-12-31 $0.21
2015-09-30 $0.15
2015-06-30 $0.11
2015-03-31 $0.08
2014-12-31 $0.09
2014-09-30 $0.15
2014-06-30 $0.15
2014-03-31 $0.10
2013-12-31 $0.27
2013-09-30 $0.18
2013-06-30 $-0.23
2013-03-31 $0.08
2012-12-31 $0.17
2012-09-30 $0.13
2012-06-30 $0.15
2012-03-31 $0.13
2011-12-31 $-0.01
2011-09-30 $0.16
2011-06-30 $0.15
2011-03-31 $0.13
2010-12-31 $0.16
2010-09-30 $0.16
2010-06-30 $0.17
2010-03-31 $0.15
2009-12-31 $0.19
2009-09-30 $0.19
2009-06-30 $0.16
2009-03-31 $0.13
2008-12-31 $0.13
2008-09-30 $0.10
2008-06-30 $0.11
2008-03-31 $0.10
2007-12-31 $0.07
2007-09-30 $-0.04
2007-06-30 $0.15
2007-03-31 $0.14
2006-12-31 $0.14
2006-09-30 $0.14
2006-06-30 $0.09
2006-03-31 $0.13
2005-12-31 $0.11
2005-09-30 $0.13
2005-06-30 $0.09
2005-03-31 $0.09
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.351B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.655B 9.08
Bio-Rad Laboratories (BIO.B) United States $18.101B 36.73
Biohaven Pharmaceutical Holding (BHVN) United States $7.535B 0.00
Emergent Biosolutions (EBS) United States $2.453B 8.82
Arcus Biosciences (RCUS) United States $2.353B 0.00
Myovant Sciences (MYOV) United Kingdom $1.344B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.156B 0.00
Zymeworks (ZYME) Canada $0.627B 0.00
Ambrx Biopharma (AMAM) United States $0.207B 0.00
SQZ Biotechnologies (SQZ) United States $0.207B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.81